Certain Lots of Syphilis Medication Recalled

July 31, 2025

Physicians who see patients with syphilis should note that there is a voluntary recall of specific lots of Bicillin® L-A (Penicillin G Benzathine Injectable Suspension) by King Pharmaceuticals LLC., a subsidiary of Pfizer.  

The recalled lots can be found at Pfizer: Bicillin Recall Letter. The Centers for Disease Control and Prevention (CDC) is not aware of any adverse events associated with this issue, and there is no indication at this time of reduced efficacy or need for retreatment. 

Considering this recall and high levels of syphilis diagnoses in the United States (as detailed in the National Overview of STIs in 2023), CDC anticipates a limited supply of Bicillin L-A moving forward. Penicillin is the only recommended treatment for pregnant patients and babies with congenital syphilis. Given this information, the CDC recommends prioritizing Bicillin L-A for treating patients who are pregnant and for infants with congenital syphilis. 

More information and full recommendations can be found on a resource created by the Minnestoa Department of Health  - Bicillin L-A® Recall and Anticipated Shortage

Latest News

Allina Health Physicians Vote to Authorize Strike

July 9, 2026

More than 130 Allina Health hospital physicians represented by Doctors Council SEIU voted last week, by a 90% margin, to authorize a strike after nearly two years of bargaining.  

MMA Launches New Program to Strengthen Physician Well-being

July 9, 2026

The MMA is launching a new program, exclusive to members, to strengthen physician well-being, reduce professional isolation, build a culture of connection, and foster sustained peer connections over time.  

State Pursuing Medicaid Expansion to Treat Incarcerated People

July 9, 2026

Minnesota is pursuing a new initiative that, if approved by the federal government, will allow state Medicaid programs to cover certain behavioral health services and medical care for chronic health conditions for incarcerated people, for up to 90 days before release.